Real‐world safety and effectiveness of pembrolizumab in Japanese patients with radically unresectable melanoma: An all‐case postmarketing surveillance in Japan

This all‐case postmarketing surveillance (PMS) survey (101 centers; February 15, 2017, to March 3, 2020) captured factors that impact the safety and effectiveness of newly initiated pembrolizumab monotherapy for the treatment of radically unresectable melanoma in Japan. Eligible patients were enroll...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamazaki, Naoya, Shimizu, Akiko, Ozaki, Masahiko, Hamada, Masahiro, Takeuchi, Noriko, Ito, Yuichiro, Maekawa, Shinichiroh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796869/
https://www.ncbi.nlm.nih.gov/pubmed/35896505
http://dx.doi.org/10.1111/1346-8138.16518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796869/
https://www.ncbi.nlm.nih.gov/pubmed/35896505
http://dx.doi.org/10.1111/1346-8138.16518

Ejemplares similares